 James Roede
Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 6 | 2023 | 486 | 2.550 |
Why?
| | Mitochondria | 10 | 2023 | 960 | 2.180 |
Why?
| | Maneb | 4 | 2020 | 9 | 2.040 |
Why?
| | Sulfhydryl Compounds | 8 | 2025 | 188 | 1.860 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 248 | 1.810 |
Why?
| | Liver | 12 | 2024 | 1882 | 1.150 |
Why?
| | Ethanol | 10 | 2024 | 621 | 1.000 |
Why?
| | Oxidation-Reduction | 15 | 2025 | 1079 | 0.970 |
Why?
| | Aldehydes | 8 | 2017 | 144 | 0.940 |
Why?
| | Thioredoxins | 8 | 2018 | 31 | 0.940 |
Why?
| | Peroxiredoxin VI | 3 | 2009 | 9 | 0.900 |
Why?
| | Pesticides | 2 | 2018 | 62 | 0.890 |
Why?
| | Homocystinuria | 3 | 2024 | 72 | 0.890 |
Why?
| | Glutathione | 10 | 2023 | 359 | 0.880 |
Why?
| | Metabolome | 4 | 2018 | 354 | 0.810 |
Why?
| | Parkinson Disease | 3 | 2020 | 552 | 0.760 |
Why?
| | Metabolomics | 5 | 2014 | 692 | 0.750 |
Why?
| | Energy Metabolism | 4 | 2025 | 928 | 0.740 |
Why?
| | Oxidative Stress | 16 | 2025 | 1327 | 0.740 |
Why?
| | Neuroblastoma | 2 | 2020 | 161 | 0.720 |
Why?
| | Neural Stem Cells | 1 | 2023 | 158 | 0.690 |
Why?
| | Proteomics | 8 | 2025 | 1114 | 0.670 |
Why?
| | Dinoprostone | 1 | 2021 | 192 | 0.650 |
Why?
| | Cyclooxygenase 2 | 1 | 2021 | 176 | 0.650 |
Why?
| | Simvastatin | 1 | 2020 | 63 | 0.630 |
Why?
| | SNARE Proteins | 1 | 2019 | 40 | 0.630 |
Why?
| | Cysteine | 5 | 2024 | 204 | 0.630 |
Why?
| | Mass Spectrometry | 5 | 2018 | 741 | 0.630 |
Why?
| | Glycolysis | 3 | 2024 | 321 | 0.590 |
Why?
| | Pyruvaldehyde | 2 | 2019 | 47 | 0.580 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.560 |
Why?
| | Aminobutyrates | 1 | 2018 | 31 | 0.550 |
Why?
| | Peroxiredoxins | 4 | 2018 | 25 | 0.540 |
Why?
| | Taurine | 1 | 2018 | 44 | 0.540 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.540 |
Why?
| | Autophagy | 1 | 2019 | 286 | 0.520 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2024 | 93 | 0.520 |
Why?
| | Trisomy | 1 | 2017 | 75 | 0.500 |
Why?
| | Environmental Pollutants | 1 | 2018 | 160 | 0.500 |
Why?
| | Fibroblasts | 1 | 2021 | 1003 | 0.470 |
Why?
| | Lysine | 4 | 2024 | 289 | 0.460 |
Why?
| | Paraquat | 2 | 2014 | 13 | 0.460 |
Why?
| | Mitochondrial Proteins | 3 | 2015 | 258 | 0.450 |
Why?
| | Fungicides, Industrial | 1 | 2014 | 7 | 0.440 |
Why?
| | Callithrix | 1 | 2013 | 12 | 0.410 |
Why?
| | Saccharum | 2 | 2025 | 77 | 0.400 |
Why?
| | Thiolester Hydrolases | 2 | 2025 | 13 | 0.390 |
Why?
| | Nanoparticles | 3 | 2025 | 469 | 0.390 |
Why?
| | Carbon | 3 | 2024 | 204 | 0.360 |
Why?
| | Cystathionine beta-Synthase | 3 | 2024 | 72 | 0.350 |
Why?
| | Neurotoxins | 1 | 2011 | 29 | 0.350 |
Why?
| | Cross-Linking Reagents | 2 | 2009 | 215 | 0.350 |
Why?
| | Mice | 23 | 2024 | 17867 | 0.330 |
Why?
| | Lipid Metabolism | 3 | 2015 | 525 | 0.330 |
Why?
| | Cell Line, Tumor | 5 | 2020 | 3408 | 0.320 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 277 | 0.320 |
Why?
| | Superoxides | 1 | 2010 | 217 | 0.310 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 91 | 0.310 |
Why?
| | Reactive Oxygen Species | 4 | 2025 | 630 | 0.310 |
Why?
| | Humans | 39 | 2025 | 139062 | 0.300 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 332 | 0.290 |
Why?
| | Animals | 27 | 2024 | 37351 | 0.290 |
Why?
| | Mice, Inbred C57BL | 14 | 2024 | 5813 | 0.280 |
Why?
| | Lactoylglutathione Lyase | 2 | 2025 | 18 | 0.270 |
Why?
| | Antioxidants | 3 | 2013 | 593 | 0.260 |
Why?
| | Cell Line | 5 | 2025 | 2876 | 0.260 |
Why?
| | Proteome | 4 | 2025 | 472 | 0.260 |
Why?
| | Silicon Dioxide | 2 | 2025 | 115 | 0.260 |
Why?
| | Computational Biology | 3 | 2017 | 650 | 0.260 |
Why?
| | Cells, Cultured | 3 | 2022 | 4182 | 0.240 |
Why?
| | Alcohol Drinking | 2 | 2011 | 820 | 0.230 |
Why?
| | Phosphoglycerate Dehydrogenase | 1 | 2025 | 6 | 0.230 |
Why?
| | Protein Carbonylation | 3 | 2017 | 55 | 0.230 |
Why?
| | Cell Differentiation | 2 | 2023 | 2000 | 0.220 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.220 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 17 | 0.220 |
Why?
| | Serine | 1 | 2025 | 142 | 0.220 |
Why?
| | Mitochondria, Liver | 3 | 2014 | 70 | 0.210 |
Why?
| | Kidney Tubules, Proximal | 1 | 2025 | 132 | 0.210 |
Why?
| | Blotting, Western | 3 | 2018 | 1230 | 0.210 |
Why?
| | Phenotype | 1 | 2012 | 3160 | 0.200 |
Why?
| | Male | 21 | 2024 | 68324 | 0.200 |
Why?
| | Tandem Mass Spectrometry | 6 | 2023 | 557 | 0.200 |
Why?
| | Aging | 1 | 2013 | 1860 | 0.200 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4339 | 0.190 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 14 | 0.180 |
Why?
| | Hematopoietic Stem Cells | 1 | 2024 | 410 | 0.170 |
Why?
| | Cyclooxygenase 1 | 1 | 2021 | 28 | 0.170 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 13 | 0.170 |
Why?
| | Thioredoxin-Disulfide Reductase | 2 | 2018 | 13 | 0.170 |
Why?
| | Superoxide Dismutase | 3 | 2017 | 353 | 0.170 |
Why?
| | HT29 Cells | 2 | 2018 | 41 | 0.170 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 44 | 0.160 |
Why?
| | Mast Cells | 1 | 2021 | 149 | 0.160 |
Why?
| | Mevalonic Acid | 1 | 2020 | 14 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 463 | 0.160 |
Why?
| | Ubiquinone | 1 | 2020 | 31 | 0.160 |
Why?
| | Methionine | 1 | 2021 | 162 | 0.160 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 29 | 0.160 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.160 |
Why?
| | Protein Transport | 2 | 2019 | 441 | 0.160 |
Why?
| | Immunoglobulin E | 1 | 2021 | 326 | 0.160 |
Why?
| | Zinc Oxide | 1 | 2019 | 9 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 648 | 0.160 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2020 | 193 | 0.150 |
Why?
| | Models, Animal | 2 | 2013 | 399 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 146 | 0.150 |
Why?
| | Zebrafish | 1 | 2023 | 501 | 0.150 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 118 | 0.150 |
Why?
| | Cell Survival | 2 | 2019 | 1132 | 0.140 |
Why?
| | Female | 13 | 2024 | 74074 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 197 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 621 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2018 | 592 | 0.140 |
Why?
| | S-Nitrosothiols | 1 | 2018 | 5 | 0.140 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.140 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2023 | 20 | 0.140 |
Why?
| | Lipid Peroxidation | 4 | 2011 | 152 | 0.140 |
Why?
| | Electron Transport | 1 | 2018 | 116 | 0.140 |
Why?
| | Hepatitis | 1 | 2017 | 47 | 0.130 |
Why?
| | Acetylation | 4 | 2024 | 245 | 0.130 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 42 | 0.130 |
Why?
| | Mice, Transgenic | 3 | 2012 | 2177 | 0.130 |
Why?
| | Amino Acids | 2 | 2018 | 500 | 0.130 |
Why?
| | Macrophages | 1 | 2024 | 1545 | 0.130 |
Why?
| | Cochlea | 2 | 1994 | 70 | 0.120 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 86 | 0.120 |
Why?
| | Skin | 1 | 2021 | 754 | 0.120 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 489 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 429 | 0.120 |
Why?
| | Cholestasis | 1 | 2018 | 210 | 0.120 |
Why?
| | Apoptosis | 3 | 2020 | 2559 | 0.120 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 365 | 0.120 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1361 | 0.120 |
Why?
| | Oxygen Consumption | 1 | 2018 | 709 | 0.110 |
Why?
| | Glycoproteins | 2 | 2021 | 359 | 0.110 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 8 | 0.110 |
Why?
| | Atrazine | 1 | 2014 | 8 | 0.110 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2602 | 0.110 |
Why?
| | Herbicides | 1 | 2014 | 27 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 2 | 2013 | 184 | 0.110 |
Why?
| | Otoacoustic Emissions, Spontaneous | 1 | 1994 | 5 | 0.110 |
Why?
| | Infant | 2 | 2019 | 9576 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 280 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2019 | 794 | 0.110 |
Why?
| | Tyrosine | 1 | 2014 | 226 | 0.100 |
Why?
| | Cadmium | 1 | 2014 | 69 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 349 | 0.100 |
Why?
| | Tryptophan | 1 | 2014 | 183 | 0.100 |
Why?
| | Azoles | 1 | 2012 | 4 | 0.100 |
Why?
| | Betaine | 2 | 2024 | 72 | 0.100 |
Why?
| | Kidney | 2 | 2023 | 1480 | 0.100 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 182 | 0.100 |
Why?
| | Phenylenediamines | 1 | 2012 | 10 | 0.100 |
Why?
| | Organoselenium Compounds | 1 | 2012 | 11 | 0.100 |
Why?
| | Auditory Perception | 1 | 1993 | 113 | 0.090 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 450 | 0.090 |
Why?
| | Homocysteine | 2 | 2024 | 160 | 0.090 |
Why?
| | Esthetics | 1 | 1992 | 47 | 0.090 |
Why?
| | Alkylation | 1 | 2012 | 27 | 0.090 |
Why?
| | Amino Acids, Sulfur | 1 | 2011 | 8 | 0.090 |
Why?
| | Otitis Media | 1 | 1994 | 167 | 0.090 |
Why?
| | Surgery, Plastic | 1 | 1992 | 46 | 0.090 |
Why?
| | Folic Acid | 2 | 2024 | 188 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2011 | 55 | 0.090 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2011 | 15 | 0.090 |
Why?
| | Carcinoma, Basal Cell | 1 | 1992 | 73 | 0.090 |
Why?
| | Immunoassay | 1 | 2012 | 112 | 0.090 |
Why?
| | Fructose | 1 | 2011 | 113 | 0.090 |
Why?
| | Neurotoxicity Syndromes | 1 | 2011 | 36 | 0.090 |
Why?
| | Regression Analysis | 1 | 2013 | 1015 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 61 | 0.080 |
Why?
| | Cytochromes c | 1 | 2010 | 61 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2011 | 94 | 0.080 |
Why?
| | Hepatocytes | 1 | 2011 | 216 | 0.080 |
Why?
| | Biomarkers | 3 | 2021 | 4115 | 0.080 |
Why?
| | Triglycerides | 2 | 2011 | 515 | 0.080 |
Why?
| | Cardiolipins | 1 | 2010 | 83 | 0.080 |
Why?
| | Buthionine Sulfoximine | 2 | 2023 | 10 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 147 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1498 | 0.080 |
Why?
| | Apolipoprotein B-100 | 1 | 2009 | 10 | 0.080 |
Why?
| | Dietary Fats | 1 | 2011 | 303 | 0.080 |
Why?
| | Fatty Liver | 1 | 2011 | 241 | 0.080 |
Why?
| | Phylogeny | 1 | 2013 | 1007 | 0.070 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2008 | 31 | 0.070 |
Why?
| | Animal Feed | 1 | 2008 | 54 | 0.070 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 270 | 0.070 |
Why?
| | Molecular Conformation | 1 | 2008 | 147 | 0.070 |
Why?
| | NF-kappa B | 2 | 2011 | 680 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 820 | 0.070 |
Why?
| | Pilot Projects | 1 | 2013 | 1763 | 0.070 |
Why?
| | Dopamine | 1 | 2011 | 309 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 6152 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2011 | 611 | 0.070 |
Why?
| | Protein Binding | 1 | 2014 | 2237 | 0.070 |
Why?
| | Models, Molecular | 2 | 2011 | 1598 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 317 | 0.070 |
Why?
| | Oxygen | 1 | 2012 | 976 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 1992 | 554 | 0.060 |
Why?
| | Glutathione Transferase | 2 | 2017 | 102 | 0.060 |
Why?
| | Glucose | 1 | 2011 | 1032 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2054 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2741 | 0.060 |
Why?
| | Glycosylation | 2 | 2019 | 162 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1049 | 0.060 |
Why?
| | Signal Transduction | 3 | 2018 | 5094 | 0.060 |
Why?
| | Influenza, Human | 1 | 2011 | 610 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 1992 | 854 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2011 | 2822 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1734 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2018 | 3584 | 0.050 |
Why?
| | Phosphorylation | 1 | 2008 | 1770 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 391 | 0.050 |
Why?
| | Gene Expression | 1 | 2008 | 1494 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2019 | 732 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2497 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 50 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2023 | 130 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1710 | 0.050 |
Why?
| | Glutathione Disulfide | 2 | 2013 | 33 | 0.050 |
Why?
| | Acoustic Stimulation | 2 | 1994 | 316 | 0.050 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 239 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2009 | 3038 | 0.050 |
Why?
| | Neurons | 1 | 2011 | 1606 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 286 | 0.050 |
Why?
| | Eye Proteins | 1 | 2021 | 92 | 0.040 |
Why?
| | Adenosylhomocysteinase | 1 | 2021 | 10 | 0.040 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2021 | 16 | 0.040 |
Why?
| | Adult | 5 | 2017 | 38389 | 0.040 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 36 | 0.040 |
Why?
| | Polyamines | 1 | 2021 | 43 | 0.040 |
Why?
| | Diet | 1 | 2008 | 1287 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 417 | 0.040 |
Why?
| | Aged | 3 | 2017 | 24236 | 0.040 |
Why?
| | Uterine Artery | 1 | 2020 | 74 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 433 | 0.040 |
Why?
| | Rats | 1 | 2008 | 5598 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2858 | 0.040 |
Why?
| | Carrier Proteins | 2 | 2017 | 739 | 0.040 |
Why?
| | Alkynes | 1 | 2019 | 61 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2163 | 0.040 |
Why?
| | Solubility | 1 | 2019 | 241 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 500 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2928 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 901 | 0.040 |
Why?
| | Surface Properties | 1 | 2019 | 411 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 65 | 0.040 |
Why?
| | Middle Aged | 3 | 2017 | 33864 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 369 | 0.030 |
Why?
| | Azo Compounds | 1 | 2017 | 29 | 0.030 |
Why?
| | Catalase | 1 | 2017 | 134 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 74 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 617 | 0.030 |
Why?
| | Chronic Disease | 2 | 2011 | 1802 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2013 | 15922 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 25 | 0.030 |
Why?
| | Toxicity Tests, Acute | 1 | 2014 | 8 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 86 | 0.030 |
Why?
| | Tympanoplasty | 1 | 1994 | 8 | 0.030 |
Why?
| | Ossicular Prosthesis | 1 | 1994 | 13 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 194 | 0.030 |
Why?
| | Hearing Loss, Conductive | 1 | 1994 | 24 | 0.030 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2014 | 37 | 0.030 |
Why?
| | Fourier Analysis | 1 | 2014 | 41 | 0.030 |
Why?
| | Acoustics | 1 | 1994 | 42 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 1994 | 5165 | 0.030 |
Why?
| | Auranofin | 1 | 2013 | 7 | 0.030 |
Why?
| | Amplifiers, Electronic | 1 | 1993 | 7 | 0.030 |
Why?
| | Auditory Threshold | 1 | 1993 | 41 | 0.030 |
Why?
| | Ear, Middle | 1 | 1993 | 84 | 0.030 |
Why?
| | Noise | 1 | 1993 | 65 | 0.020 |
Why?
| | DNA Primers | 1 | 2014 | 509 | 0.020 |
Why?
| | Isoindoles | 1 | 2012 | 4 | 0.020 |
Why?
| | Facial Neoplasms | 1 | 1992 | 19 | 0.020 |
Why?
| | Administration, Oral | 1 | 2014 | 790 | 0.020 |
Why?
| | Hearing | 1 | 1993 | 118 | 0.020 |
Why?
| | Prosthesis Design | 1 | 1994 | 332 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 983 | 0.020 |
Why?
| | Nuclear Localization Signals | 1 | 2011 | 18 | 0.020 |
Why?
| | Time Factors | 2 | 2014 | 6885 | 0.020 |
Why?
| | Biological Assay | 1 | 2011 | 129 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 112 | 0.020 |
Why?
| | Metabolic Detoxication, Phase I | 1 | 2010 | 6 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 82 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 498 | 0.020 |
Why?
| | Surgical Flaps | 1 | 1992 | 141 | 0.020 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2010 | 49 | 0.020 |
Why?
| | NAD | 1 | 2011 | 79 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2010 | 105 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 68 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 361 | 0.020 |
Why?
| | Cytoplasm | 1 | 2011 | 270 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2182 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2051 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 850 | 0.020 |
Why?
| | Protein Subunits | 1 | 2010 | 242 | 0.020 |
Why?
| | Wound Healing | 1 | 1992 | 347 | 0.020 |
Why?
| | Intracellular Space | 1 | 2009 | 68 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 958 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 6874 | 0.020 |
Why?
| | Tubulin | 1 | 2009 | 145 | 0.020 |
Why?
| | Cell Death | 1 | 2009 | 376 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2011 | 532 | 0.020 |
Why?
| | Models, Biological | 1 | 1994 | 1818 | 0.020 |
Why?
| | Microtubules | 1 | 2009 | 280 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1992 | 1069 | 0.010 |
Why?
| | Weight Loss | 1 | 2011 | 785 | 0.010 |
Why?
| | Lipids | 1 | 2009 | 676 | 0.010 |
Why?
| | Cytokines | 1 | 2011 | 2084 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2486 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 1992 | 7698 | 0.010 |
Why?
|
|
Roede's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|